PURPOSE. Meibomian gland dysfunction (MGD) is a primary cause of dry eye disease. One of the risk factors for MGD is exposure to 13-cis retinoic acid (13-cis RA), a metabolite of vitamin A. However, the mechanism is not well understood. We hypothesize that 13-cis RA inhibits cell proliferation, promotes cell death, alters gene and protein expressions, and attenuates cell survival pathways in human meibomian gland epithelial cells.
1
These effects of 13-cis RA on the meibomian gland are not surprising. This agent (first marketed as Accutane [isotretinoin] by F. Hoffmann-La Roche Ltd., Basel, Switzerland) is frequently used for the dermatologic treatment of severe acne, because it significantly decreases the growth, development, and lipid production of sebaceous gland epithelial cells (sebocytes). 7, 8 Given that the meibomian gland is a large sebaceous gland, it is not surprising that 13-cis RA exerts an analogous impact on this tissue. However, the influence of 13-cis RA may become an even greater health problem in the near future. The reason is that RA, which is converted to all-trans retinoic acid in sebocytes, 9 is the key ingredient of antiaging cosmetics. These skin creams are commonly sold for use around the eyelids and could promote the development of MGD in a population (i.e., aged) known to be very susceptible to the development of dry eye. 10 Indeed, this antiaging cosmetic use could become a significant challenge to the effective treatment of dry eye disease, given that approximately 25% of the US population will be 65 years of age and older by the year 2050.
The mechanism(s) by which 13-cis RA induces MGD is unknown. It has been shown that 13-cis RA causes alterations in sebocyte gene expression, decreases basal sebocyte proliferation, prohibits sebocyte terminal differentiation, induces sebocyte apoptosis, and suppresses sebum production up to 90%. 8, 11 We hypothesize that retinoic acid derivatives act on the meibomian gland in a manner analogous to that of the Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc. www.iovs.org j ISSN: 1552-5783 sebaceous gland. More specifically, we hypothesize that 13-cis RA inhibits cell proliferation, promotes cell death, alters gene and protein expressions, and attenuates cell survival pathways in human meibomian gland epithelial cells. We propose to test these hypotheses in the current study.
MATERIALS AND METHODS

Cell Culture and Treatment
Immortalized human meibomian gland epithelial cells 12 were maintained in keratinocyte serum-free medium (KSFM) supplemented with 5 ng/mL epidermal growth factor (EGF) and 50 lg/mL bovine pituitary extract (BPE; Invitrogen Corp., Carlsbad, CA) as previously described. 13 Immortalized human conjunctival cells (gift of Ilene Gipson, Schepens Eye Research Institute, Boston, MA) were maintained in KSFM supplemented with 5 ng/mL EGF and 25 lg/mL BPE. 13-cis Retinoic acid (13-cis RA; Sigma-Aldrich, St. Louis, MO) was reconstituted in 100% ethanol to 10 mM and stored under argon gas at À208C, protected from light. All procedures involving RA were performed under dim yellow light.
Cell Proliferation Assay
To assess cell proliferation in response to 13-cis RA, 40,000 or 20,000 cells were seeded in 6-or 12-well plates (Corning Inc., Corning, NY), respectively, and treated with or without varying doses of 13-cis RA for times specified. Following treatment, cells were trypsinized and counted manually using a hemocytometer (Bright-Line; American Optical Corporation, Buffalo, NY). For the WST-1 assay (Roche Diagnostics, Indianapolis, IN), cells were plated in 96-well plates and assessed according to the manufacturer's instructions. Each assay was repeated in at least three independent experiments.
Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling (TUNEL) Staining
To assay for apoptosis, cells were grown on four-well chamber slides (Lab-Tek II; Thermo Fisher Scientific, Rockford, IL) and exposed to 13-cis RA for 4 days. Samples were processed using a commercial cell death detection kit (In Situ Cell Death Detection Kit; Roche Diagnostics), following the manufacturer's instructions. Labeled dUTP alone without deoxynucleotidyl transferase was used as a negative control and DNase-Itreated cells served as positive controls. Fluorescent images were captured with commercial software (Advanced Software, version 4.0.9; SPOT Imaging Solutions, division of Diagnostic Instruments, Inc., Sterling Heights, MI) on a brightfield and epifluorescence microscope (Nikon Eclipse E800; Nikon Instruments, Inc., Melville, NY).
Annexin V/Propidium Iodide (PI) Flow Cytometric Analysis
To quantify the cell death event, flow cytometric analysis was performed on cells labeled with Annexin V and PI. Cells were treated with varying doses of 13-cis RA in six-well plates for 24 hours. Staurosporin (Sigma-Aldrich) was used to induce apoptosis and hydrogen peroxide (CVS Pharmacy, Woonsocket, RI) to induce necrosis. Samples were collected and stained with Annexin V and PI using a commercial kit (ApopNexin FITC Apoptosis Detection Kit; Chemicon International, Temecula, CA), according to the manufacturer's instructions. For each sample, 300,000 events were collected. Data were analyzed using commercial software (Summit Software, v4.3; Beckman Coulter, Inc., Fullerton, CA) and percentages of cells in early apoptosis and late apoptosis/necrosis were compared using one-way ANOVA followed by Fisher's protected least significant difference (PLSD).
Microarray Gene Expression Analysis
Microarray gene expression analysis was performed to identify specific genes and pathways in meibomian gland cells that are affected by exposure to 13-cis RA. Cells were treated with 2 lM 13-cis RA or ethanol control for 4 days and total RNA was extracted using a commercial kit (RNeasy Mini Kit; Qiagen, Inc., Valencia, CA), according to the manufacturer's instructions. The RNA concentrations and 260/280 nm ratios were determined using a spectrophotometer (NanoDrop 1000; Thermo Scientific, Waltham, MA). RNA integrity was analyzed using commercial RNA bioanalyzer (RNA Nano 6000 Series II Chip with a Bioanalyzer 2100; Agilent Technologies, Palo Alto, CA). The RNA samples were processed commercially (Asuragen, Austin, TX) for quantitation of mRNA levels using microarray expression analysis (HumanHT-12 v.4 Expression BeadChips; Illumina, San Diego, CA), as described previously. 14 Background subtracted, cubic spline normalized, nonlogtransformed data were evaluated with commercial software (available in the public domain at GeneSifter.net; Geospiza, Seattle, WA). Standardized hybridization intensity values were adjusted by adding a constant, such that the lowest intensity value for any sample equaled 16. 15 Gene expression data were analyzed with Student's t-test (two-tailed, unpaired). All data are accessible for download through the National Center for Biotechnology Information's Gene Expression Omnibus (available in the public domain at http://www.ncbi.nlm.nih.gov/ geo) via series accession number GSE37089.
SDS-PAGE and Immunoblots
To further investigate the gene expression array data, protein levels were studied using immunoblotting. Following treatment with 1 lM 13-cis RA or ethanol, cells were directly lysed in SDS sample buffer (Bio-Rad, Hercules, CA) supplemented with 1% protease inhibitor cocktail (Sigma-Aldrich) and 5% beta-mercaptoethanol (Sigma-Aldrich). Lysates were heated at 958C for 10 minutes, separated by SDS-PAGE on 4%-20% Trisglycine precast gels (Invitrogen Corp.), and transferred to polyvinylidene difluoride membranes. Monoclonal antibodies specific for phospho-AKT (Ser473; Cell Signaling Technology, Inc., Danvers, MA), pan-AKT (Cell Signaling Technology, Inc.), interleukin-1b (IL-1b, provided by National Cancer Institute, Bethesda, MD), matrix metalloproteinase-9 (MMP-9; Abcam, Cambridge, MA), and b-actin (Cell Signaling Technology, Inc.) were used. For phospho-AKT and IL-1b, membranes were blocked with 5% bovine serum albumin in Tris-buffered saline containing 0.1% Tween-20 (TBS/T); for all other antibodies, membranes were blocked with 5% nonfat dry milk in TBS/T. All primary antibodies were diluted 1:1000 in blocking buffer except for b-actin (1:5000). Horseradish peroxidase-conjugated secondary antibodies were goat antirabbit IgG and Fcspecific goat antimouse IgG (Sigma-Aldrich). Proteins were visualized with commercial Western blotting substrate (Pierce ECL Western Blotting Substrate; Thermo Fisher Scientific).
Zymography for MMP-9
Gelatinase activity due to MMP-9 in the culture media was assessed by gelatin zymography. Supernatants were separated by SDS-PAGE on 7.5% acrylamide gels containing 1 mg/mL gelatin, with MMP control-6 (Sigma-Aldrich) as a positive control. To remove SDS and reveal enzyme activity, gels were Influence of 13-cis RA on Meibomian Gland Cells IOVS j June 2013 j Vol. 54 j No. 6 j 4342 incubated in renaturation buffer (5% 1 M Tris, 1% 0.5 M CaCl 2 , 2.5% Triton X-100) overnight at room temperature, then in development buffer (5% 1 M Tris, 1% 0.5 M CaCl 2 ) for 24 hours at 378C. Finally, gels were stained in buffer containing 40% methanol, 10% acetic acid, 0.5% Coomassie Blue dye. MMP activity was visible as clear bands against blue background.
Statistical Analyses
One-way ANOVA, two-way ANOVA, and Student's t-test were performed using commercial software (Prism 5; GraphPad Software, Inc., La Jolla, CA). Fisher's PLSD was used as a post hoc test for one-way ANOVA (StatView512þ; Abacus Corporation, Canoga Park, CA). For all tests, statistical significance was considered to be P < 0.05.
RESULTS
Effect of 13-cis RA on the Proliferation of Human Meibomian Gland Epithelial Cells
To determine the effect of 13-cis RA on meibomian gland cell proliferation, we performed both time course and doseresponse studies. We also examined whether possible 13-cis RA influence was unique to these cells, or represented a general toxic effect on other cell types (e.g., human conjunctival epithelial cells). At a concentration of 2 lM, 13-cis RA significantly inhibited cell proliferation after 2, 3, and 4 days of treatment (Fig. 1A) .
Moreover, meibomian gland epithelial cells at both early and late passages showed a dose-dependent decrease in cell number after 4 days of treatment with 1, 2, 5, and 10 lM 13-cis RA (Fig. 1B) . In fact, no countable cells were observed in wells exposed to 5 or 10 lM 13-cis RA, and only rounded, poorly adherent cells remained ( Fig. 2A ). This dose-dependent decrease in cell number was also confirmed by WST-1 assay, a colorimetric assay based on the reduction of the tetrazolium salt WST-1 by mitochondrial dehydrogenase in viable cells (Fig.  1C) .
The meibomian gland epithelial cells appeared to be more sensitive to 13-cis RA than other cell types such as conjunctival cells, whose proliferation was not inhibited by 1 lM 13-cis RA (Fig. 2B) , and whose cell morphology remained unchanged with up to 5 lM 13-cis RA treatment ( Fig. 2A) . However, conjunctival epithelial cell morphology was altered by exposure to the high dose of 13-cis RA (i.e., 10 lM), and appeared similar to that of meibomian gland epithelial cells ( Fig. 2A) .
Influence of 13-cis RA on Cell Death
To assess the influence of 13-cis RA on apoptosis, human meibomian gland epithelial cells were treated with vehicle, 1, 2, or 5 lM 13-cis RA, and then processed for TUNEL staining. We observed more TUNEL-positive cells in the 13-cis RAtreated condition (Fig. 3A) . To quantify the cell death event, we stained cells treated with vehicle, 0.1, 1, or 2 lM RA for 24 hours with FITC dye-conjugated Annexin V, which specifically binds to phosphatidylserine that translocates from the inner membrane leaflet to the outer membrane surface in the early event of apoptosis; and propidium iodide (PI), which binds to DNA in cells with compromised membranes (during late apoptosis or necrosis, where cells show early membrane permeabilization). Cells were sorted by flow cytometry and positive cells classified into early apoptosis (Annexin V positive, PI negative) or late apoptosis/necrosis (Annexin V and PI positive) groups. We observed a dose-dependent increase in the percentage of cells in late apoptosis/necrosis after 24 hours of treatment with 13-cis RA (Fig. 3B) . In contrast, we did not observe any difference in early apoptosis events in cells treated for 4 hours (data not shown). As control experiments, staurosporin and hydrogen peroxide were used to induce apoptosis and necrosis, respectively. Staurosporin treatment (1 lM, 3 hours) increased the percentage of cells in early apoptosis but not in late apoptosis/necrosis (Fig. 3C) . By contrast, 0.5 mM hydrogen peroxide treatment for 3 hours increased the prevalence of both early apoptosis and late apoptosis/necrosis; after 24 hours, the percentage of cells in both groups was further increased, with a greater increase in late apoptosis/necrosis (Fig. 3C) .
Influence of 13-cis RA on Gene Expression in Human Meibomian Gland Epithelial Cells
To assess whether 13-cis RA alters gene expression in human meibomian gland cells, we treated cells with vehicle or 2 lM 13-cis RA for 4 days (n ¼ 3/group) and then processed the RNA for evaluation (Expression BeadChips; Illumina, and GeneSifter.net software; Geospiza). We chose these conditions based on the pronounced proliferation phenotype we had observed previously (Fig. 1A) .
Our analysis demonstrated that 13-cis RA significantly (P < 0.05) altered the expression of thousands of genes (3520 ; 3206 ) in human meibomian gland epithelial cells. As shown in Table 1 , these included an upregulation of genes for various inflammatory mediators (e.g., IL-36c, IL-15, IL-8, and IL-1b) and proteases (e.g., matrix metallopeptidase 9 [MMP-9]), and a downregulation of genes for tyrosine kinase signaling (e.g., nerve growth factor b) and cell division (e.g., cell division cycle 25 homolog C).
Exposure to 13-cis RA had a marked effect on many Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, biological processes, molecular functions, and cellular components in human meibomian gland epithelial cells. As demonstrated in Table 2 , 13-cis RA enhanced the expression of genes related to lysosomes, mitogen-activated protein kinase signaling, apoptosis, cell death, and lytic vacuoles. 13-cis RA also upregulated the activity of six genes associated with keratinization (e.g., small proline-rich proteins SPRRs 2F, 2D, and 1B). Conversely, 13-cis RA suppressed genes in processes linked to DNA replication, cell cycle, RNA transport and binding, and mitochondria. 
Effect of 13-cis RA on IL-1b and MMP-9 Protein Levels in Human Meibomian Gland Epithelial Cells
Our finding that 13-cis RA upregulated the expression of IL-1b and MMP-9 genes was of particular interest, given that these proteins have been linked to the development of dry eye disease. 4 Consequently, we sought to determine whether these augmented transcript levels are translated into heightened inflammatory and protease protein content.
As shown in Figure 4 , treatment of human meibomian gland epithelial cells with 13-cis RA led to a significant increase in the levels of pro-IL-1b, IL-1b, and MMP-9 proteins in cell lysates (Fig. 4A) . This effect was noticeable as early as 2 hours after 13-cis RA exposure. In addition, we observed elevated MMP-9 activity (Fig. 4B ) and increased accumulation of pro-IL-1b (Fig.  4C ) in supernatants of 13-cis RA-treated cells.
Impact of 13-cis RA on AKT Signaling
To test our hypothesis that 13-cis RA reduces the activity of cell survival mediators, we explored whether this RA metabolite decreases phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT) signaling. Such a signal, as indicated by AKT phosphorylation, promotes cell growth, proliferation, and survival. 16 In addition, AKT is a component of the phosphatidylinositol (PI) signaling system, which was significantly influenced by 13-cis RA (Table 2) .
We discovered that 13-cis RA caused a significant, timedependent decrease in the levels of phosphorylated AKT. This effect, as evidenced by a reduction in the phosphorylated, 60-kDa AKT band, began at 8 hours, and lasted at least until 24 hours, after treatment (Fig. 4A) . 13-cis RA also increased the expression of another phosphorylated band, which migrated at approximately 50 kDa (Fig. 4A ). This second band, which was Early apoptosis was defined as Annexin V positive, PI negative; late apoptosis or necrosis was defined as positive for both Annexin V and PI. Representative scatter dot graphs are shown in the top panel, and quantification in the bottom panel. One-way ANOVA followed by Fisher's PLSD post hoc test were used to determine significance (P < 0.05), and different letters denote significant (P < 0.05) differences among the groups. (C) Representative scatter dot graphs of control and agents known to induce apoptosis (staurosporin) and necrosis (H 2 O 2 ). not seen in SaOS-2 osteosarcoma and LNCaP prostate cancer cells (data not shown), is in the molecular mass range for a caspase-cleaved AKT fragment. 17, 18 
DISCUSSION
Vitamin A plays a wide range of roles in cell proliferation, differentiation, apoptosis, and organ development. 19 However, active vitamin A metabolites, such as 13-cis RA, may also be toxic. 13-cis RA is the key ingredient of isotretinoin (Accutane), a drug used to treat acne, as well as in cosmetics advertised to reduce wrinkles and delay the appearance of aging. Unfortunately, 13-cis RA can have serious adverse effects on the meibomian gland, leading to ductal keratinization and obstruction, gland atrophy, gland drop out, and poor quality of meibomian gland secretions (i.e., meibum). 1, 20 These signs are the hallmarks of MGD, a major cause of dry eye disease. In this study, we have started to address the mechanism of 13-cis RAinduced MGD at the cellular level, including inhibition of cell proliferation, promotion of cell death, alteration of gene expression, induction of the inflammatory mediators IL-1b and MMP-9, and reduced activation of the survival/proliferation signal AKT.
Our microarray data from human meibomian gland epithelial cells show that expression of genes related to proliferation decreases, and of those associated with cell death increases, in response to treatment with 13-cis RA. We confirmed these effects using proliferation assays and cell death analyses. 13-cis RA is known to inhibit proliferation and induce apoptosis in sebaceous gland cells. 8 Further, it is used as an antitumor drug in the treatment of various cancer types, including acute promyelocytic leukemia, head and neck squamous cell carcinoma, ovarian carcinoma, bladder cancer, and neuroblastoma. 21 However, the mechanisms of cell cycle arrest and cell death induction remain an important question. It has been shown that 13-cis RA-induced growth arrest in MCF-7 cells involves reduced PI3K/AKT signaling. 22 The PI3K/ AKT pathway is an important regulator of cell cycle progression and cell survival. 13-cis RA reduced phosphorylated AKT in human meibomian gland epithelial cells within 8 hours, and the signal remained suppressed for as long as 24 hours, with continuous treatment. 13-cis RA also stimulated the expression of a lower molecular weight, immunoreactive AKT species, which appears to be analogous to that following caspase-induced AKT cleavage. 17, 18 We believe that suppression of the AKT pathway may be one of the primary mechanisms by which 13-cis RA inhibits proliferation and induces cell death in meibomian gland epithelial cells.
As to the mode of cell death, by staining cells with Annexin V and PI, and sorting by flow cytometry, we found that 13-cis RA induces a significant number of cells to enter late apoptosis/necrosis, but not early apoptosis (Fig. 3B) . Interestingly, using the same Annexin V/PI technique to assay sebaceous gland cells treated with 13-cis RA, Nelson et al. 8 identified an increase in late apoptosis without any change in the prevalence of early apoptosis. This assay cannot differentiate between late apoptosis and necrosis, and thus 13-cis RA may increase apoptosis or necrosis. However, in our data, the similar percentage of cells undergoing early apoptosis, regardless of dose or length of exposure to 13-cis RA, suggests that 13-cis RA may induce necrosis, rather than apoptosis, in meibomian gland cells. Further, control experiments using staurosporin and hydrogen peroxide demonstrated that immortalized meibomian gland cells are capable of undergoing both apoptosis and necrosis. This conclusion does not contradict our TUNEL assay results, because TUNEL, which detects nicked DNA ends, stains both necrotic and apoptotic cells. 23 Recently it has been recognized that, similar to apoptosis, necrosis is also a type of programmed cell death, 24 and it is regulated by cellular machinery composed of an increasing list of factors. 25 The mechanism of necrosis Relative ratios were calculated by comparing the degree of gene expression from vehicle-and 13-cis RA-treated human meibomian gland epithelial cells. Selected genes had a comparative P value (between treatments) of <0.05 and a known identity. regulated by 13-cis RA will be an interesting subject for future studies. 13-cis RA significantly increased the expression of a variety of genes encoding inflammatory mediators, including IL-1b, IL-8, IL-15, and IL-36c in human meibomian gland epithelial cells. These cytokines, which serve as chemoattractants, Jak kinase and NF-jB activators, and/or regulators of leukocyte function 26 (http://www.genecards.org), could theoretically promote extravasation of immune cells into the adjacent conjunctiva in vivo. Such conjunctival inflammation, termed blepharitis, may occur during MGD. 27,28 13-cis RA also upregulated the transcription and translation of MMP-9 and IL-1b, both of which have been implicated in the pathophysiology of dry eye disease. 4, 29, 30 In addition to their roles as inflammatory mediators at the ocular surface, IL-1b and MMP-9 are also involved in regulation of cell death. For example, IL-1b promotes pancreatic epithelial cell death by inducing endoplasmic reticulum stress and activating c-Jun NH(2)-terminal protein kinase (JNK). 31 Interestingly, our microarray data show that the JNK cascade is upregulated by 13-cis RA (Table 1) . MMP-9 promotes cell death and inhibits cell proliferation in cultured human keratinocytes 32 and MMP-9 deficiency protects against retinal ganglion cell death. 33 Thus, it is possible that 13-cis RA promotes meibomian gland epithelial cell death, in part, via IL-1b and MMP-9. This hypothesis needs to be addressed in future studies.
13-cis RA significantly enhanced the expression of genes encoding SPRRs 1B, 2D, and 2F in human meibomian gland epithelial cells. Similarly, we have previously found that the levels of SPRR mRNAs (e.g., 2A, 2E, 2F, and 3) are significantly increased in meibomian glands from patients with MGD.
14 If translated, it is possible that such upregulated SPRRs may be responsible, at least in part, for the hyperkeratinization of meibomian gland ductal epithelium in MGD. The reason is that SPRRs are known to promote keratinization, [34] [35] [36] [37] [38] and this process is believed to be a primary cause of MGD. 1, 39, 40 In conclusion, at the outset of this study, we hypothesized that 13-cis RA alters meibomian gland epithelial cell gene expression, reduces the activity of cell survival mediators, inhibits proliferation, and induces meibocyte cell death. Our findings support our hypotheses, and suggest that 13-cis RA may act on the meibomian gland in a manner analogous to that of the sebaceous gland. A z-score is a statistical rating of the relative expression of genes, and depicts over-or underrepresentation in a given gene list. 41 Positive z-scores reflect gene ontology terms with a greater number of genes meeting the criterion than is expected by chance, whereas negative z-scores represent fewer genes meeting the criterion than expected by chance; z-scores with values > 2.0 or less than À2.0 are significant. High and low values for the placebo (Pl) and 13-cis RA (RA) groups in specific ontologies are highlighted in bold print. RA Genes , number of genes upregulated in 13-cis RAtreated meibomian gland epithelial cells, as compared with those of the ''placebo'' group; Pl Genes , number of genes upregulated in the placebotreated meibomian gland epithelial cells, as compared with those of the ''RA'' group; z-score, specific score for the upregulated gene ontology in the placebo-and 13-cis RA-exposed human meibomian gland epithelial cells. 
